Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Korean Air requires Ebola declarations for all US-bound passengers

Korean Air will require all passengers traveling to the United States to submit an Ebola-related declaration confirming they have not visited or stayed in the Democratic Republic of the Congo within the previous 21 days, as part of new U.S. health measures. The airline said Monday the requirement will take effect for flights departing at or after 1:59 p.m. Wednesday, following an administrative…

Korean Air requires Ebola declarations for all US-bound passengers

Korean Air has announced a new requirement for all passengers heading to the United States. Starting from 1:59 p.m. on Wednesday, travelers must submit an Ebola-related declaration. This declaration must confirm that they have not been to the Democratic Republic of the Congo in the last 21 days. This measure is part of new U.S. health protocols aimed at preventing the spread of Ebola from the Democratic Republic of the Congo.

The requirement applies to all U.S.-bound routes, including those for U.S. citizens, residents, airline crew members, visitors, and passengers who are transiting through the United States. Anyone who has been in Congo within the past three weeks will not be permitted to board a U.S.-bound flight. Even passengers who only changed planes at an airport in Congo, without leaving the airport, will be treated as having traveled to the country and will face entry restrictions. Passengers are required to complete and submit this declaration before boarding.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at koreatimes.co.kr →

More in Health & Medicine

Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation

Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation.

  • King's College London scientists developed KCL-286 drug for Alzheimer's.
  • KCL-286 repairs DNA damage, reduces brain inflammation, targets multiple aspects.
  • Drug activates retinoic acid pathway protein, could speed up drug development.

Africa: Ebola outbreak kills more than 5,300 people

Africa’s latest Ebola outbreak has killed more than 5,300 people, the vast majority of them in the Democratic Republic of Congo, according to the continent’s top health agency. In mid-May, the DRC declared its 17th Ebola outbreak, a deadly disease transmitted through contact with bodily fluids that causes haemorrhagic fever and has killed…

More from Tuesday 3 November →